Archive for Author: Afsaneh Naimollah

Dear Clients and Friends, Click here to see the full HIT Market Update including Capital Raise and M&A transactions. Earlier this month, we joined the 45,000 healthcare enthusiasts at HIMSS in Las Vegas. Rather than covering the obvious themes of interoperability, blockchains or the cloud, here are some of our not-so-obvious key takeaways. The tech giants had many representatives who flew undercover – Apple had no booth. Amazon’s booth was not labeled Amazon, but “AWS”, their cloud platform. Google’s messaging was somewhat opaque. Despite the secrecy, these companies appear intent to bring the Silicon Valley innovation culture to healthcare. We…

Read More

Dear Clients and Friends, Read more from our February 2018 HIT Market Update here. Last month we shared Part I of our predictions for the New Year covering new risk models, EMR as a platform, and blockchains as the new infrastructure. Here is Part II of our outlook for the year. Valuations of mid to late stage companies could see lower altitudes. Even though 2017 was a banner year for digital health funding at a record $5.8 billion, in many ways, it fell short of expectations. There were no IPOs in the digital health space in 2017, and M&A volume…

Read More

Dear Clients and Friends, Read more from our January 2018 HIT Market Update here. Once again it is time to try our hand at predicting the trends that will shape the course of the New Year. Here is our Part I. A different approach to risk management will drive the largest partnerships and M&A transactions. The pending CVS/Aetna and Humana/Kindred acquisitions are not about reducing duplicate costs or adding customers to increase scale. They are about the need to offer a more complete service. The argument is that control over value chain will translate into a more efficient organization with…

Read More